Offer - Urjas Oil for just ₹ 1 X
Karplat 450 mg Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Ovarian Cancer. Karplat 450 mg Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Karplat 450 mg Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Karplat 450 mg Injection can also lead to other problems, which have been listed below. These side effects of Karplat 450 mg Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Karplat 450 mg Injection's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Karplat 450 mg Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Karplat 450 mg Injection related warnings section.
Karplat 450 mg Injection is contraindicated in people with pre-existing medical conditions like Anemia, Neutropenia, Infections as it can result in adverse effects. Other conditions have been mentioned below in the Karplat 450 mg Injection contraindications section.
Besides this, Karplat 450 mg Injection may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Karplat 450 mg Injection is considered not safe while driving, and is not addictive.
Karplat 450 mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Is the use of Karplat 450 mg Injection safe for pregnant women?
Karplat should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Karplat 450 mg Injection safe during breastfeeding?
Karplat should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Karplat 450 mg Injection on the Kidneys?
Karplat can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Karplat 450 mg Injection on the Liver?
There are no any side effects of Karplat on the liver.
What is the effect of Karplat 450 mg Injection on the Heart?
Karplat is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Karplat 450 mg Injection unless your doctor advises you to do so -
Is this Karplat 450 mg Injection habit forming or addictive?
No, there is no any evidence that Karplat 450 mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Karplat 450 mg Injection as you may feel sleepy.
Is it safe?
Karplat 450 mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Karplat 450 mg Injection is not used to treat mental disorders.
Interaction between Food and Karplat 450 mg Injection
Taking Karplat 450 mg Injection with food does not harm your health.
Interaction between Alcohol and Karplat 450 mg Injection
Information about the interaction of Karplat 450 mg Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 282-283
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 862
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Paraplatin® (carboplatin)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Carboplatin Accord(carboplatin)